Inventor · disambiguated record
Henry Lowe
Also filed as: LOWE HENRY · LOWE HENRY I C
11 granted patents·5 pending applications·14 citations·filing 2012–2021
84Inventor score
Top patents by PatentIndex Score
16 records- 0188US9687469B2Agent containing flavonoid derivatives for treating cancer and inflammationLOWE HENRY·Filed 2015·Granted Jun 27, 2017·5 cites·1 claims
- 0283US10398674B2Therapeutic agents containing cannabis flavonoid derivatives targeting kinases, sirtuins and oncogenic agents for the treatment of cancersFLAVOCURE BIOTECH LLC·Filed 2015·Granted Sep 3, 2019·4 cites·2 claims
- 0381US8715748B2Methods for inhibiting prostate cancer by kinases and angiogenesis inhibitory mechanisms of ball moss extractLOWE HENRY·Filed 2013·Granted May 6, 2014·2 cites·5 claims
- 0480US10278950B2Therapeutic agents containing cannabis flavonoid derivative for ocular disordersLOWE HENRY I C·Filed 2016·Granted May 7, 2019·2 cites·2 claims
- 0576US10765660B2Agent containing flavonoid derivatives for treating cancer and inflammationLOWE HENRY·Filed 2017·Granted Sep 8, 2020·1 cites·7 claims
- 0672US11141401B2Therapeutic agents containing cannabis flavonoid derivatives targeting kinases, sirtuins and oncogenic agents for the treatment of cancersLOWE HENRY·Filed 2019·Granted Oct 12, 2021·0 cites·10 claims
- 0771US2020253918A1Therapeutic agents containing cannabis flavonoid derivatives targeting kinases, sirtuins and oncogenic agents for the treatment of cancersLOWE HENRY·Filed 2019·Application pending·0 cites
- 0868US9040100B2Methods for inhibiting prostate cancer by kinases and angiogenesis inhibitory mechanisms of ball moss extractLOWE HENRY·Filed 2014·Granted May 26, 2015·0 cites·1 claims
- 0966US2021121437A1Therapeutic agents containing cannabis flavonoid derivatives targeting kinases, sirtuins and oncogenic agents for the treatment of multiple myeloma, lymphoma, and leukemiaLOWE HENRY·Filed 2020·Application pending·0 cites
- 1063US10632098B2Therapeutic agents containing cannabis flavonoid derivative for ocular disordersLOWE HENRY I C·Filed 2019·Granted Apr 28, 2020·0 cites·8 claims
- 1160US2020016094A1Therapeutic cannabinoid derivatives composition as histamine 2 (h2) blocking agentsLOWE HENRY·Filed 2019·Application pending·0 cites
- 1260US2021369642A1Therapeutic cannabinoid derivatives composition as histamine 2 (h2) blocking agentsLOWE HENRY·Filed 2021·Application pending·0 cites
- 1352US2018353462A1Therapeutic agents containing cannabis flavonoid derivatives targeting kinases, sirtuins and oncogenic agents for the treatment of cancersLOWE HENRY·Filed 2016·Application pending·0 cites
- 1448US8907117B2Anti-tumor and anti-inflammatory dicinnamoyl-glycerol esters and their analoguesLOWE HENRY·Filed 2012·Granted Dec 9, 2014·0 cites·1 claims
- 1543US10751320B2Therapeutic agents containing cannabis flavonoid derivatives for the prevention and treatment of neurodegenerative disordersFLAVOCURE BIOTECH LLC·Filed 2016·Granted Aug 25, 2020·0 cites·5 claims
- 1642US9814747B2Methods for inhibiting HIV-1 activity by inhibitory mechanisms of extracts of Guaiacum officinale L. (zygophyllaceae)LOWE HENRY·Filed 2015·Granted Nov 14, 2017·0 cites·9 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →